DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Food and Drug Administration.
Jakafi (ruxolitinib) tablets.
Reference ID: 4191667. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202192s015lbl.pdf. Accessed December 8, 2021
We do not assume any responsibility for the contents of the web pages of other providers.